Diagnosis and treatment of adenosquamous carcinoma of the pancreas

( views:, downloads: )
Author:
WANG Hong-cheng(Department of Surgery, Shanghai Sixth People' s Hospital, Shanghai Jiaotong University, Shanghai 200233, China)
HUANG Xin-yu(Department of Surgery, Shanghai Sixth People' s Hospital, Shanghai Jiaotong University, Shanghai 200233, China)
Journal Title:
CHINESE JOURNAL OF PANCREATOLOGY
Issue:
Volume 9, Issue 04, 2009
DOI:
10.3760/cma.j.issn.1674-1935.2009.04.011
Key Word:
Pancreatic neoplasms; Adenocarcinoma; Carcinoma, squamous cell; Prognosis

Abstract: Objective To summarize the experience in the diagnosis and treatment of adenosquamous carcinoma of the pancreas to better our understanding of this rare exocrine pancreatic neoplasm. Methods The clinical data of five cases of adenosquamous carcinoma of pancreas admitted between July 2002 and June 2008 were analyzed retrospectively, and relevant literature was reviewed and discussed. Results Pancreatic adenosquamous carcinoma was found in 3 men and 2 women with a mean age of 64 ± 18 years old. Tumor was located in the head of pancreas in 2 patients, body and tail in 3 cases. One patient was submitted to pancreaticoduodenectomy, three patients underwent distal pancreatectomy and splenectomy and one had cholecystojejunostomy and gastric bypass surgery, as well as 1251 implantation. The mean size of the tumor was 4.5 cm. One patient had posterior stomach wall, descending duodenum, portal vein involvement; spleen was invaded in 2 cases; neural and vessel invasion was present in 2 cases. Lymph node metastasis was present in 1 case. Pathologically primary tumor and liver metastasis were mixture of adenocarcinoma and squamous cell carcinoma. In all 5 patients with complete follow up, 3 died of tumor recurrence or liver metastasis with a mean postoperative survival time of 11.2 momths (8.5 ~ 13.5 months). The other 2 cases survived for 6 and 56 months , respectively. Conclusions Pancreatic adenosquamous carcinoma was likely to be found in patients in their 60s, and confirmative diagnosis was difficult. The prognosis of this rare tumor appeared to be dismal due to the high degree of malignancy.

  • [1]Hsu JT,Yeh CN,Chen YR,et al.Adenosquamous carcinonla of the pancreas.Digestion,2005,72:104-108
  • [2]Motojima K,Tomioka T,Kohara N,et al.Immunohistochemical characteristics of adenosquamous carcinoma of the pancreas.J Surg Oncol,1992,49:58-62.
  • [3]Madura TA,Jarman BT,Doherty MG,et al.Adenosquamous carcinoma of the pancreas.Arch Surg,1999,134:599-603.
  • [4]Yamaguchi K,Enjoji M.Adenosquamous carcinoma of the pancreas:a clinicopathologic study.J Surg Oncol,1991,47:109-116.
  • [5]Kardon DE,Thompson LD,Przygodzki RM,et al.Adenosquamous carcinoma of the pancreas:a clinicopathologic series of 25 cases.Mod Pathol,2001,14:443-451.
  • [6]陈泉宁,王益林,王建承,等.7例胰腺腺鳞癌的临床诊治.外科理论与实践,2007:12,237-240.
  • [7]Murakami Y,Yokoyama T,Yokoyama Y,et al.Adenosquamous carcinoma of the pancreas:preoperative diagnosis and molecular alterations.J Gastroenterol,2003,38:1171-1175.
  • [8]Rahemtullah A,Misdraji J,Pitman MB.Adenosquamous carcinoma of the pancreas:cytologic features in 14 cases.Cancer,2003,99:372-378.
  • [9]Nabae T,Yamaguchi K,Takahata S,et al.Adenosquamous carcinonm of the pancreas:report of two cases.Am J Gastroenterol,1998,93:1167-1170.
  • [10]Kuji I,Sunfiya H,Taki J,et al.Intense Ga-67 uptake in adenosquamous carcinoma of the pancreas.Ann Nucl Med,1997,11:41-43.
  • [11]Inoue T,Nagao S,Tajima H,et al.Adenosquamous pancreatic cancer producing parathyroid hormone-related protein.J Gastroenterol,2004,39:176-180.
  • [12]Ito K,Fujita N,Noda Y,et al.Pancreatic adenosquamous carcinoma,9 mm in size,diagnosed preoperatively by transpapillary biopsy:report of a case.Digestion Endoscopy,2003,15:235-239.
  • [13]Smoot RL,Zhang L,Sebo TJ,et al.Adenosquamous carcinoma of the pancreas:a single-institution experience comparing resection and palliative care.J Am Coll Surg,2008,207:368-370.
  • [14]Yanlaue H,Tanimura H,Onishi H,et al.Adenosquamous carcinoma of the pancreas:successful treatment with extended radical surgery,intraoperative radiation therapy,and locoregional chemotherapy.Int J Gastrontest Cancer,2001,29:53-58.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn